Intrinsic Value of S&P & Nasdaq Contact Us

Frequency Therapeutics, Inc. FREQ NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.40
+367.3%

Stock Statistics — FREQ

Frequency Therapeutics, Inc. (FREQ) has a market capitalization of $10.94M and trades at $0.30. The 52-week range is 0.183-5.59.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-12.48, annual revenue of $6.39M.

The stock has a beta of 0.77, operates in the Healthcare sector.

Trading Data
Current Price$0.30
52-Week Range0.183-5.59
Volume309.16K
Avg Volume (30D)135.08K
Market Cap$10.94M
Beta (1Y)0.77
Company
IPO Date2019-10-03
Employees46
CEODavid L. Lucchino
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS5009461089
CUSIP35803L108
Income (Latest Year)
Revenue$6.39M
EBITDA$-121.86M
Operating Income$-121.86M
Net Income$-117.26M
EPS$-12.48
EPS Diluted$-12.48
Shares Outstanding$9.4M
Balance Sheet (Latest Year)
Total Assets$113.51M
Current Assets$82.37M
Cash & ST Investments$75.16M
Total Liabilities$62.07M
Total Debt$43.49M
Net Debt$21.66M
Total Equity$51.44M
Debt / Equity0.85
Valuation Ratios
P/E Ratio-0
P/S Ratio1.71
P/B Ratio0.21
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message